who? If you say so... well what can I say. You claim homeopathy and generation rescue is the answer when these children were helped through individual biochemical analysis and individualized treatment programs.... such as the ones found here: www.hriptc.org I'll give you an E for effort though.
http://www.hriptc.org/schizophreniahome.html>>What do you hope for?
Less dependence on medications? A more normal life and future for someone you love?
Welcome to Pfeiffer Treatment Center. We are pioneers in the development of biochemical therapies for behavioral, and cognitive disorders. Our approach restores hope, health and balance for children, teens and adults who suffer from depression, bipolar disorder, anxiety, post partum depression*, mood disorders and schizophrenia. Our method is based on the science of the relationship between brain chemistry and neurotransmitter function. Our technique brings relief to people who may have lost hope - and gives them a chance to lead a more normal life.
Pfeiffer provides a world of relief for Depression, Mood Disorders and Schizophrenia. Here is how. We provide a personalized approach. Each of us has an individual biochemical make-up that influences mood and behavior. Pfeiffer's personalized diagnostic and therapeutic approach identifies specific biochemical imbalances and provides therapies that improve mental health, behavior and cognitive function.
Care surrounds you and your family. Our physicians, nurses and other medical professionals take the time to work with you, re-balancing biochemistry and restoring functional behavior.
Customized therapies without side effects typically experienced with drugs. Expertly-trained pharmacists compound individualized therapies from only the purest vitamins, minerals and other nutrient products available worldwide.
Partnership with your physician. Biochemical therapies complement and augment treatments provided by your primary doctor and other medical professionals.
Supporting you with resources. Support groups, educational conferences and professional resources provide the services you need.
*Post Partum Depression therapy is available for women who have consulted their Obstetrician or their primary physician.<<
Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):15-9.
Autism and immunity: revisited study.
Castellani ML, Conti CM, Kempuraj DJ, Salini V, Vecchiet J, Tete S, Ciampoli C, Conti F, Cerulli G, Caraffa A, Antinolfi P, Galzio R, Shaik Y, Theoharides TC, De Amicis D, Perrella A, Cuccurullo C, Boscolo P, Felaco M, Doyle R, Verrocchio C, Fulcheri M.
Autism spectrum disorder is of interest neurochemically because it represents a relatively homogeneous disorder with regard to disease development, abnormal cognitive development and intellectual development disturbance. A consistent finding in autistic children is a high number of mast cells and a high level of serotonin which is also found at elevated concentrations in the urine of autistic patients. In addition, a dysfunction of clinical conditions, such as gastrointestinal and immunological symptoms, is frequently noted in autistic children, however, IgE does not appear to be prevalent in these children but probably an increase of cytokines/chemokines produced by mast cells at an early age may play an important role. Therefore an immune hypothesis, involving also autoimmunity, is one possible pathogenetic mechanism in autism. In conclusion, mast cell activation could contribute to immune and neuroinflammatory abnormalities that are evident in patients with autism spectrum disorders.
PMID: 19309548
Association of family history of autoimmune diseases and autism spectrum disorders.
Atladóttir HO, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B, Eaton WW, Parner ET.
Nanea, Department of Epidemiology, Institute of Public Health, bNational Centre for Register-Based Research, and eInstitute of Medical Microbiology and Immunology, University of Aarhus, Aarhus, Denmark. hoa@soci.au.dk
OBJECTIVES: Recent studies suggest that familial autoimmunity plays a part in the pathogenesis of ASDs. In this study we investigated the association between family history of autoimmune diseases (ADs) and ASDs/infantile autism. We perform confirmatory analyses based on results from previous studies, as well as various explorative analyses. METHODS: The study cohort consisted of all of the children born in Denmark from 1993 through 2004 (689 196 children). Outcome data consisted of both inpatient and outpatient diagnoses reported to the Danish National Psychiatric Registry. Information on ADs in parents and siblings of the cohort members was obtained from the Danish National Hospital Register. The incidence rate ratio of autism was estimated by using log-linear Poisson regression. RESULTS: A total of 3325 children were diagnosed with ASDs, of which 1089 had an infantile autism diagnosis. Increased risk of ASDs was observed for children with a maternal history of rheumatoid arthritis and celiac disease. Also, increased risk of infantile autism was observed for children with a family history of type 1 diabetes. CONCLUSIONS: Associations regarding family history of type 1 diabetes and infantile autism and maternal history of rheumatoid arthritis and ASDs were confirmed from previous studies. A significant association between maternal history of celiac disease and ASDs was observed for the first time. The observed associations between familial autoimmunity and ASDs/infantile autism are probably attributable to a combination of a common genetic background and a possible prenatal antibody exposure or alteration in fetal environment during pregnancy.
PMID: 19581261
Autoimmunity in autism.
Enstrom AM, Van de Water JA, Ashwood P.
University of California at Davis, Department of Medical Microbiology and Immunology/UC Davis MIND Institute, 2805 50th Street, Sacramento, CA 95817, USA.
Autism spectrum disorders is a heterogenous group of neurodevelopmental disorders, the etiology or etiologies of which remain unknown. Increasing evidence of autoimmune phenomena in individuals with autism could represent the presence of altered or inappropriate immune responses in this disorder, and this immune system dysfunction may represent novel targets for treatment. Furthermore, in recent studies, antibodies directed against the fetal brain have been detected in some mothers of children with autism; these antibodies have the ability to alter behavioral outcomes in the offspring of animal models. A better understanding of the involvement of the immune response in early brain development, with respect to autism, may have important therapeutic implications.
PMID: 19431079